Concerned Doctors

Location

Alabama

On call

All the time
  • Home
  • Our Board
    • Jordan Vaughn, MD
    • David Calderwood, MD
    • Stewart Tankersley, MD
    • David L. Williams, MD
  • Events
    • Birmingham Covid Truth Full Video
    • Covid Truths September 19, 2:30 – 5pm – Birmingham Marriott
    • Covid Truth Summit The Westin Huntsville, November 14th, 2021
    • COVID Truths Doctors’ Forum-Montgomery Oct 26, 2021
  • Brochure
    • Covid brochure
    • Brochure references
  • Podcast
    • Intro: Peter McCullough interviews Stewart Tankersley, MD. and Jordan Vaughn, MD.
    • Episode 1 – Your Patient’s Health Should Supplant ‘Public’ Health
    • Episode 2 – Reject the Government’s Request to ‘Control Your Freedom’
    • Episode 3 – Informed Consent Has Been Replaced, the Result is Medical Tyranny
    • Episode 4 – Was it a Failed Response or a Forced Crisis?
    • Episode 5 – What is the Composition of ‘THE SCIENCE’ You Speak Of?
    • Episode 6 – Did the Elites Move the Goal Post or Only Recently Post the Real Goals?
  • Press
    • CONCERNED DOCTORS WILLING TO ASSIST ALL CANDIDATES
    • CONCERNED DOCTORS CALL FOR IMMEDIATE END OF COVID-19 VACCINES AND BOOSTERS FOR MINORS
  • Donate
  • Volunteer
  • Subscribe
  • FAQ
  • Breaking

Study finds fenofibrate may downgrade Covid-19 to common cold level

Home » breaking news » Study finds fenofibrate may downgrade Covid-19 to common cold level

By admin • September 26, 2021 • No Comments

The researchers observed that the virus changes lipid metabolism in human lungs. They believe that halting this process could help prevent the onset of problems that increase the severity of the disease. While SARS-CoV-2 hinders the ability of the body to break down fat, fenofibrate starts this process by binding and activating the DNA site that is blocked by the virus. Nahmias was quoted by The Times of Israel as saying: “The interesting thing about our study is that fenofibrate actually binds and activates the very site on the DNA that the virus shuts down — a part of our DNA that allows our cells to burn fat. “Virus infection causes the lung cells to start building up fat, and fenofibrate allows the cells to burn it.” This mechanism of the drug could reduce the virus’ ability to reproduce or even make it disappear. Nahmias added: “Your body can easily deal with the virus, all we need to do is deal with the symptoms. We need to give the body time to clear the virus without going into respiratory failure.

 


“And it’s by doing this that I think we can transform it into something far less serious, something like the common cold.” The Jerusalem Post noted that the researchers are advancing the drug into animal studies in New York, the US and intend to fast-track clinical trials in Israel and the US within the coming weeks.

Study finds fenofibrate may downgrade Covid-19 to common cold level

https://www.timesofisrael.com/existing-drug-may-downgrade-covid-threat-to-common-cold-level-jerusalem-study/

 

https://www.news24.com/you/news/new-study-finds-cholesterol-lowering-drug-could-reduce-coronavirus-symptoms-to-level-of-a-common-cold-20200721

Facebook
Twitter
Categories:breaking news

admin

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Copyright © Foundation for Concerned Doctors and Patients | Design by TallyThemes
  • Q & A
  • FAQ
  • Masks
  • Find a Doc
  • Find Meds
  • Protocols
  • Physicians
  • Exemptions
  • Legal Assistance
  • Share your story
  • Nuremberg Code
  • Rome Declaration
  • Speaker request form
  • Monoclonal Antibodies
  • Safety and Effectiveness
  • Declaration of Helsinki
  • Protocol for Long Haul COVID-19